Fezile Ozdemir, Emrah Dural, Nilay Sedes Baskak, Yağmur Kır, Bora Baskak and H. Sinan Suzen* Pages 1 - 10 ( 10 )
Aims and Objective: The plasma level of mirtazapine (MIR) varies between individuals primarily depending on the differences in metabolism during pharmacotherapy. CYP2D6 takes role as a major enzyme in MIR metabolism and POR enzyme donates electron to CYP2D6 for its activity. Single nucleotide polymorphisms in the genes encoding pharmacokinetic enzymes may cause changes in enzyme activity, leading to differences in metabolism of drug. Our aim was to assess the influence of CYP2D6*4 and POR*28 polymorphisms on MIR plasma levels in Turkish psychiatric patients.
Materials and Methods: The association between genetic variations and plasma level of MIR were investigated on 54 patients. CYP2D6*4 and POR*28 polymorphisms were analysed using Polymerase Chain Reaction- Restriction Fragment Length Polymorphism (PCR-RFLP) and plasma MIR levels were measured using HPLC.
Results: Allele frequencies of CYP2D6*4 and POR*28 were 0.11 and 0.39, respectively in the study population. The results showed that CYP2D6*4 allele carriers have higher C/D MIR levels while POR*28 allele carriers have lower C/D MIR levels. Combined genotype analyses also revealed that individuals with CYP2D6*1/*1 - POR*28/*28 genotype have statistically lower C/D MIR level (0.95 ng/ml/dose) when compared with individuals with CYP2D6*1/*1 - POR*1/*1 genotype (1.52 ng/ml/dose).
Conclusion: Our results indicate that CYP2D6*4 and POR*28 polymorphisms may have a potential in the explanation of differences of plasma levels in MIR treated psychiatric patients. Combination of these variations may be beneficial increasing drug response and decreasing adverse drug reactions in MIR psychopharmacotherapy.
Mirtazapine, CYP2D6*4, POR*28, plasma, HPLC, MIR psychopharmacotherapy.
Department of Forensic Toxicology, Institute of Forensic Sciences, Ankara University, Ankara, Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Cumhuriyet University, Sivas, Department of Psychiatry, Yıldırım Beyazıt University Yenimahalle Research and Training Hospital, Ankara, Department of Psychiatry, School of Medicine, Ankara University, Ankara, Department of Psychiatry, School of Medicine, Ankara University, Ankara, Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Ankara University, Ankara